Organon (OGN) Short term Debt (2020 - 2026)
Organon (OGN) recorded quarterly Short term Debt of $16.0 million in Q1 2026, little changed quarter-over-quarter from $16.0 million in Q4 2025, and down 20.0% on a YoY basis from $20.0 million in Q1 2025.
Organon (OGN) Short term Debt (2020 - 2026) Analysis & Trends
Organon's Short term Debt history runs 7 years deep, the most recent figure standing at $16.0 million for Q1 2026.
- In Q1 2026, Short term Debt fell 20.0% year-over-year to $16.0 million; the TTM figure through Mar 2026 stood at $16.0 million (down 20.0% YoY), while the FY2025 annual figure was $16.0 million, down 20.0% from the prior year.
- Short term Debt was $16.0 million for Q1 2026 at Organon, roughly flat from $16.0 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $115.0 million in Q2 2025 to a low of $8.0 million in Q3 2022.
- Historically, Short term Debt has averaged $19.2 million across 5 years, with a median of $9.0 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Short term Debt sank 99.41% in 2022, then jumped 1177.78% in 2025.
- A 5-year view of Short term Debt shows it stood at $8.0 million in 2022, then rose by 12.5% to $9.0 million in 2023, then jumped by 122.22% to $20.0 million in 2024, then dropped by 20.0% to $16.0 million in 2025, then changed by 0.0% to $16.0 million in 2026.
- The last three Short term Debt figures came in at $16.0 million (Q1 2026), $16.0 million (Q4 2025), and $45.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn |
| 10 | Organon | 3.49 Bn | 2.37 Bn | 783.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.00 Mn |
| Dec 31, 2025 | 16.00 Mn |
| Sep 30, 2025 | 45.00 Mn |
| Jun 30, 2025 | 115.00 Mn |
| Mar 31, 2025 | 20.00 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Sep 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Dec 31, 2023 | 9.00 Mn |
| Sep 30, 2023 | 8.00 Mn |
| Jun 30, 2023 | 8.00 Mn |
| Mar 31, 2023 | 8.00 Mn |
| Dec 31, 2022 | 8.00 Mn |
| Sep 30, 2022 | 8.00 Mn |
| Jun 30, 2022 | 9.00 Mn |
| Mar 31, 2022 | 9.00 Mn |
| Dec 31, 2021 | 9.00 Mn |
| Sep 30, 2021 | 39.00 Mn |
| Mar 31, 2021 | 1.52 Bn |